P

PVLA

PVLA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
PVLA Live QuoteReal-time
$145.77
+$19.19(+15.16%)1M
Day Range$144.25 – $150.80
Open$146.44
Previous Close$146.58
Volume150.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$2.13B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-5.50
Price to Book10.8
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $145.77 (68%)
Low: $72.22High: $179.95
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$233.44+55.6% upside

Insider Buys

0

$0

Insider Sales

2

$4.12M

Total Volume

$4.12M

19 transactions

Net Activity

$4.12M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys17 sells

$2.64B total

J
2

Jenkins George M

Dir

0 buys1 sells

$3.58M total

G
3

Goin Kathleen

COO

0 buys1 sells

$537K total

Trading History
PVLA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 21, 2026

1 months ago

Goin Kathleen

COO

COO
Sell4.3K$124.58$537K

Oct 12, 2026

1 months ago

Jenkins George M

Dir

Director
Sell27.5K$130.16$3.58M

Sep 16, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Sep 11, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell173.6K$-27500.00$0

Sep 2, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell250$-313.00$0

Aug 19, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Jul 15, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Jun 17, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

May 20, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Apr 15, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Mar 30, 2026

7 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell201.1K$445.00$89.50M

Mar 18, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Feb 27, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell200.7K$4000.00$802.75M

Feb 18, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Jan 21, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Dec 17, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Nov 19, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-4302.00$0

Apr 9, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell196.7K$4990.00$981.47M

Dec 18, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell191.7K$4000.00$766.79M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PVLA Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

PVLA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PVLA

Over the last 90 days, corporate insiders at PVLA (PVLA) engaged in a total of 19 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 2 were sales. The total volume of insider trading reached $4.12M.

The net insider activity for PVLA shows a net selling bias of $4.12M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 196.7K shares valued at $981.47M on Apr 9, 2025.

Live Market News & Developments
Aggregated real-time headlines for PVLA (PVLA)
6 updates

Palvella Therapeutics (PVLA) Stock Looks Above Fair Value After 51% Gain

Yahoo Finance SingaporeYesterday

Palvella will introduce a third drug candidate from its treatment platform tomorrow.

Stock TitanYesterday

PVLA - Palvella Therapeutics Inc Stock Price and Quote

Finviz176d ago

Palvella Therapeutics: First Approval Could Unlock A Rare-Disease Commercial Flywheel

Seeking Alpha94d ago

PVLA Forecast — Price Target — Prediction for 2027

TradingView145d ago

Is Palvella Therapeutics (PVLA) Fully Valued Ahead Of QTORIN Approval?

Yahoo Finance104d ago

FAQs About PVLA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PVLA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PVLA is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 2 sales by company executives over the last 90 days.

The CEO Conviction Index for PVLA is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.